Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

ClinicalTrials.gov ID: NCT02345031

Public ClinicalTrials.gov record NCT02345031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss.

Study identification

NCT ID
NCT02345031
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Autifony Therapeutics Limited
Industry
Enrollment
78 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2015 (Type not available)
Primary completion
May 2016 (Actual)
Completion
Jun 2016 (Actual)
Last update posted
Aug 9, 2018

2015 – 2016

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Sacramento ENT Sacramento California 95815 —
Colorado ENT and Allergy Colorado Springs Colorado 80909 —
ENT Associates of South Florida Boca Raton Florida 33487 —
QPS MRA (Miami Research Associates) Miami Florida 33143 —
University of South Florida Tampa Florida 33620 —
University of Louisville Louisville Kentucky 40202 —
Mayo Clinic Rochester Minnesota 55095 —
The University of Mississippi Medical Center Jackson Mississippi 39216 —
Long Island Jewish Medical Center New Hyde Park New York 11042 —
PMG Research Inc. Wilmington North Carolina 28401 —
Piedmont Ear, Nose, & Throat Associates Winston-Salem North Carolina 27103 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Jean Brown Research Murray Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02345031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02345031 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →